U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C22H28F2O5
Molecular Weight 410.4515
Optical Activity UNSPECIFIED
Defined Stereocenters 9 / 9
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FLUMETHASONE

SMILES

[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]3(F)[C@@]2([H])C[C@H](F)C4=CC(=O)C=C[C@]34C

InChI

InChIKey=WXURHACBFYSXBI-GQKYHHCASA-N
InChI=1S/C22H28F2O5/c1-11-6-13-14-8-16(23)15-7-12(26)4-5-19(15,2)21(14,24)17(27)9-20(13,3)22(11,29)18(28)10-25/h4-5,7,11,13-14,16-17,25,27,29H,6,8-10H2,1-3H3/t11-,13+,14+,16+,17+,19+,20+,21+,22+/m1/s1

HIDE SMILES / InChI

Molecular Formula C22H28F2O5
Molecular Weight 410.4515
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 9 / 9
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: Description was created based on several sources, including

Flumethasone or flumetasone is a corticosteroid and is an agonist of a glucocorticoid receptor with anti-inflammatory, antipruritic and vasoconstrictive properties. Flumethasone is often formulated as the pivalic acid ester, flumetasone pivalate. The immune system is suppressed by corticosteroids due to a decrease in the function of the lymphatic system, a reduction in immunoglobulin and complement concentrations, the precipitation of lymphocytopenia, and interference with antigen-antibody binding. Flumethasone binds to plasma transcortin, and it becomes active when it is not bound to transcortin. Flumethasone is used for the treatment of contact dermatitis, atopic dermatitis, exczema, psoriasis, diaper rash and other skin condition.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
LOCORTEN

Approved Use

This medication is used in corticosteroid-responsive dermatoses.
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
10 ng/mL
5 mg single, intravenous
dose: 5 mg
route of administration: Intravenous
experiment type: SINGLE
co-administered:
FLUMETHASONE serum
Equus caballus
population: HEALTHY
age: UNKNOWN
sex: FEMALE / MALE
food status: UNKNOWN
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
5.32 ng × h/mL
5 mg single, intravenous
dose: 5 mg
route of administration: Intravenous
experiment type: SINGLE
co-administered:
FLUMETHASONE serum
Equus caballus
population: HEALTHY
age: UNKNOWN
sex: FEMALE / MALE
food status: UNKNOWN
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
1.1 h
5 mg single, intravenous
dose: 5 mg
route of administration: Intravenous
experiment type: SINGLE
co-administered:
FLUMETHASONE serum
Equus caballus
population: HEALTHY
age: UNKNOWN
sex: FEMALE / MALE
food status: UNKNOWN
PubMed

PubMed

TitleDatePubMed
Determination of flumethasone in calf urine and serum by liquid chromatography-tandem mass spectrometry.
2001 May 5
A high-performance liquid chromatography/tandem mass spectrometric screening method for eight synthetic corticosteroids in bovine feces and the simultaneous differentiation between dexamethasone and betamethasone.
2002
Immunochemical screening and liquid chromatographic-tandem mass spectrometric confirmation of drug residues in edible tissues of calves injected with a therapeutic dose of the synthetic glucocorticoids dexamethasone and flumethasone.
2003 Jan 1
Effect of steroidal and non-steroidal anti-inflammatory drugs in combination with long-acting oxytetracycline on non-specific immunity of calves suffering from enzootic bronchopneumonia.
2003 Oct 8
Otic drops used to clear a blocked grommet: an in vitro prospective randomized controlled study with blinded assessment.
2004 Dec
Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties.
2004 Sep
Regression of subcorneal pustular dermatosis type of IgA pemphigus lesions with azithromycin.
2005 Aug
Effect of steroidal and non-steroidal anti-inflammatory drugs on inflammatory markers in calves with experimentally-induced bronchopneumonia.
2005 Jul-Aug
A chromatography method for the screening and confirmatory detection of dexamethasone.
2006 Dec
Medical treatment of vulvar squamous cell hyperplasia.
2006 Dec
Rapid multi-residue method for the quantitative determination and confirmation of glucocorticosteroids in bovine milk using liquid chromatography-electrospray ionization-tandem mass spectrometry.
2007 Apr 4
Flexor carpi ulnaris tendonopathy in a Weimaraner.
2007 Oct
A liquid chromatography method using a monolithic column for the determination of corticoids in animal feed and animal feeding water.
2008 Aug
Optimization of solid phase extraction clean up and validation of quantitative determination of corticosteroids in urine by liquid chromatography-tandem mass spectrometry.
2008 Jun 9
Validation of a solid-phase extraction and ultra-performance liquid chromatographic tandem mass spectrometric method for the detection of 16 glucocorticoids in pig tissues.
2009 Mar-Apr
Determination of anabolic steroids in muscle tissue by liquid chromatography-tandem mass spectrometry.
2009 Nov 13
Generic sample preparation combined with high-resolution liquid chromatography-time-of-flight mass spectrometry for unification of urine screening in doping-control laboratories.
2010 Apr
Quantitative determination of corticosteroids in bovine milk using mixed-mode polymeric strong cation exchange solid-phase extraction and liquid chromatography-tandem mass spectrometry.
2010 Dec 1
Screening and quantitative confirmatory method for the analysis of glucocorticoids in bovine milk using liquid chromatography-tandem mass spectrometry.
2010 Sep-Oct
Patents

Sample Use Guides

Apply a sparingly thin layer of 0.02% cream, ointment or lotion over affected areas bid-tid for 7-10 days.
Route of Administration: Topical
In Vitro Use Guide
Flumethasone inhibited PAF-induced N-PMN (neutrophils from newborn calves) aggregation at the highest dose - 122 uM
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:38:02 GMT 2023
Edited
by admin
on Fri Dec 15 16:38:02 GMT 2023
Record UNII
LR3CD8SX89
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FLUMETHASONE
GREEN BOOK   MI   USAN  
USAN  
Official Name English
FLUMETHASONE [USAN]
Common Name English
U-10,974
Code English
NSC-54702
Code English
6α,9-Difluoro-11β,17,21-trihydroxy-16α-methylpregna-1,4-diene-3,20-dione
Systematic Name English
FLUMETHASONE [GREEN BOOK]
Common Name English
FLUCORT
Brand Name English
FLUMETHASONE [MI]
Common Name English
U-10974
Code English
flumetasone [INN]
Common Name English
FLUMETASONE
INN   WHO-DD  
INN  
Official Name English
Flumetasone [WHO-DD]
Common Name English
PREGNA-1,4-DIENE-3,20-DIONE, 6,9-DIFLUORO-11,17,21-TRIHYDROXY-16-METHYL-, (6.ALPHA.,11.BETA.,16.ALPHA.)-
Systematic Name English
Classification Tree Code System Code
WHO-ATC D07BB01
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
WHO-VATC QD07CB05
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
WHO-VATC QD07BB01
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
WHO-VATC QD07XB01
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
CFR 21 CFR 522.960A
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
CFR 21 CFR 520.960
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
WHO-ATC D07AB03
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
WHO-VATC QS02CA02
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
WHO-ATC D07CB05
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
NCI_THESAURUS C521
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
CFR 21 CFR 522.960
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
CFR 21 CFR 522.960C
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
WHO-ATC D07XB01
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
WHO-VATC QD07AB03
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
WHO-ATC S02CA02
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
CFR 21 CFR 524.960
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
WHO-VATC QH02AB90
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
Code System Code Type Description
ECHA (EC/EINECS)
218-370-9
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
PRIMARY
CHEBI
34764
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
PRIMARY
DRUG CENTRAL
4548
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
PRIMARY
EPA CompTox
DTXSID2045365
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
PRIMARY
NSC
54702
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
PRIMARY
RXCUI
4458
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
PRIMARY RxNorm
CHEBI
31623
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
PRIMARY
SMS_ID
100000080687
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
PRIMARY
CAS
2135-17-3
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
PRIMARY
FDA UNII
LR3CD8SX89
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
PRIMARY
WIKIPEDIA
FLUMETASONE
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
PRIMARY
EVMPD
SUB07698MIG
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
PRIMARY
ChEMBL
CHEMBL1201392
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
PRIMARY
MERCK INDEX
m5439
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
PRIMARY Merck Index
PUBCHEM
16490
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
PRIMARY
DAILYMED
LR3CD8SX89
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
PRIMARY
DRUG BANK
DB00663
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
PRIMARY
NCI_THESAURUS
C65717
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
PRIMARY
INN
1355
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
PRIMARY
MESH
D005443
Created by admin on Fri Dec 15 16:38:02 GMT 2023 , Edited by admin on Fri Dec 15 16:38:02 GMT 2023
PRIMARY
Related Record Type Details
DEGRADENT -> PARENT
Related Record Type Details
ACTIVE MOIETY